Cargando…

High preoperative blood levels of HE4 predicts poor prognosis in patients with ovarian cancer

ABSTRACT: The aim of this study was to assess the clinical value of preoperative blood levels of HE4 as a predictor of overall survival in patients with ovarian cancer and to validate previous data of HE4 and the ROMA algorithm including HE4 and CA125 in discriminating benign and malignant ovarian t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalapotharakos, Grigorios, Asciutto, Christine, Henic, Emir, Casslén, Bertil, Borgfeldt, Christer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480899/ https://www.ncbi.nlm.nih.gov/pubmed/22909379 http://dx.doi.org/10.1186/1757-2215-5-20

Ejemplares similares

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer
por: Kolkova, Zuzana, et al.
Publicado: (2012)

14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology
por: Asciutto, Katrin Christine, et al.
Publicado: (2020)

A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients
por: Leandersson, Pia, et al.
Publicado: (2020)

Normalizing to GADPH jeopardises correct quantification of gene expression in ovarian tumours – IPO8 and RPL4 are reliable reference genes
por: Kolkova, Zuzana, et al.
Publicado: (2013)

HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia
por: Ørbo, Anne, et al.
Publicado: (2016)

Correction: The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2018)

The economic burden of human papillomavirus-related precancers and cancers in Sweden
por: Östensson, Ellinor, et al.
Publicado: (2017)

Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden
por: Dobilas, Arturas, et al.
Publicado: (2023)

Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses
por: Pitta, Denise da Rocha, et al.
Publicado: (2013)

Interaction between serum levels of Anti-Mullerian Hormone and the degree of sperm DNA fragmentation measured by sperm chromatin structure assay can be a predictor for the outcome of standard in vitro fertilization
por: Zarén, Peter, et al.
Publicado: (2019)

Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
por: Shiratori, Fumiaki, et al.
Publicado: (2021)

Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer
por: YANG, ZHIJUN, et al.
Publicado: (2013)

Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency
por: Ida, Hjelmér, et al.
Publicado: (2021)

The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation
por: Nenonen, Hannah A., et al.
Publicado: (2019)

Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer
por: Furrer, Daniela, et al.
Publicado: (2019)

Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection
por: Shen, Shun-Li, et al.
Publicado: (2014)

Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960–2014: A population-based cohort study
por: Leandersson, Pia, et al.
Publicado: (2021)

Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study
por: Feng, Li-yuan, et al.
Publicado: (2020)

Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas
por: Auezova, Raushan, et al.
Publicado: (2016)

Preoperative Hyponatremia And Hypocalcemia Predict Poor Prognosis In Elderly Gastric Cancer Patients
por: Xu, Jingxuan, et al.
Publicado: (2019)

Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer
por: Sallinen, Hanna, et al.
Publicado: (2014)

Association of preoperative IL-6 levels with overt HE in patients with cirrhosis after TIPS
por: Li, JinYu, et al.
Publicado: (2023)

Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam
por: Huy, Nguyen Vu Quoc, et al.
Publicado: (2018)

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
por: Xu, Tao, et al.
Publicado: (2020)

Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses
por: Song, Liyun, et al.
Publicado: (2023)

The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
por: Krenn-Pilko, S, et al.
Publicado: (2014)

High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer
por: Tingting, Hong, et al.
Publicado: (2017)

High preoperative white blood cell count determines poor prognosis and is associated with an immunosuppressive microenvironment in colorectal cancer
por: Weng, Meilin, et al.
Publicado: (2022)

Promotion of Cervical Screening among Long-term Non-attendees by Human Papillomavirus Self-sampling
por: Ernstson, Avalon, et al.
Publicado: (2021)

Co‐testing in cervical screening among 40‐ to 42‐year‐old women is unreasonable
por: Borgfeldt, Christer, et al.
Publicado: (2022)

Early clearance of serum HE4 and CA125 in predicting platinum sensitivity and prognosis in epithelial ovarian cancer
por: Rong, Yan, et al.
Publicado: (2021)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer
por: Huang, Yan, et al.
Publicado: (2021)

Plasma exosomal caveolin-1 predicts Poor Prognosis in Ovarian Cancer
por: Yang, Lijuan, et al.
Publicado: (2021)

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
por: Liu, Duanyang, et al.
Publicado: (2018)

High Preoperative Plasma Fibrinogen Independently Predicts a Poor Prognosis in Patients with Nonmetastatic RCC
por: Wang, Zhan, et al.
Publicado: (2020)

Elevated preoperative platelet distribution width predicts poor prognosis in Esophageal Squamous Cell Carcinoma
por: Song, Qian, et al.
Publicado: (2019)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0coh6iq8vcvi126k83f79eqd12